ICUI übertreffen die 35 der letzten 39Schätzungen.
90%
Nächster Bericht
Datum des nächsten Berichts
25. Feb. 2026
Estimate forQ4 25(Revenue/ EPS)
$542.44M
/
$1.72
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+1.01%
/
-14.85%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
-12.74%
/
-18.48%
ICU Medical Inc earnings per share and revenue
On 06. Nov. 2025, ICUI reported earnings of 2.02 USD per share (EPS) for Q3 25, beating the estimate of 1.46 USD, resulting in a 38.85% surprise. Revenue reached 536.99 million, compared to an expected 520.65 million, with a 3.14% difference. The market reacted with a +8.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 1.72 USD, with revenue projected to reach 542.44 million USD, implying an decrease of -14.85% EPS, and increase of 1.01% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
What were ICU Medical Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ICU Medical Inc reported EPS of $2.02, beating estimates by 38.85%, and revenue of $536.99M, 3.14% above expectations.
How did the market react to ICU Medical Inc's Q3 2025 earnings?
The stock price moved up 8.09%, changed from $129.67 before the earnings release to $140.16 the day after.
When is ICU Medical Inc expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for ICU Medical Inc's next earnings report?
Based on 8
analysts, ICU Medical Inc is expected to report EPS of $1.72 and revenue of $542.44M for Q4 2025.